QASSAY
LIVE

Serial Number

79423205

Owner

P4Q Health, S.L.

Attorney

aoi nawashiro

Filing Date

Mar 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

QASSAY Trademark

Serial Number: 79423205 • Registration: 8131810

QASSAY is a trademark filed by P4Q Health, S.L. on March 11, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

P4Q Health, S.L.

Nuestra Señora de la Guía 19

Entity Type: 98

Trademark Details

Filing Date

March 11, 2025

Registration Date

February 10, 2026

Published for Opposition

December 23, 2025

Goods & Services

Medical diagnostic apparatus for testing for viruses; medical diagnostic testing instruments for use in immunoassay procedures to test for cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies and infectious diseases; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical diagnostic apparatus being digital rapid test readers for detecting and quantifying biomarkers and analytes related to cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies and infectious diseases and embedded software for the monitoring and management of the previously mentioned conditions

Recorded computer software for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies and infectious diseases; downloadable computer software for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies and infectious diseases; downloadable application software for the detection and quantification of biomarkers and analytes; recorded computer software using artificial intelligence (AI) for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies and infectious diseases; downloadable computer software using artificial intelligence (AI) for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies and infectious diseases; downloadable application software using artificial intelligence (AI) for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies and infectious diseases; testing apparatus for the detection and quantification of biomarkers and analytes for diagnostic purposes, namely food testing

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 10, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION PROCESSED BY IB
Dec 18, 2025 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 3, 2025 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 2, 2025 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 21, 2025 CNSA
NEW REPRESENTATIVE AT IB RECEIVED
Nov 7, 2025 NREP
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2025 TROA
REFUSAL PROCESSED BY IB
Oct 10, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 24, 2025 RFCS
REFUSAL PROCESSED BY MPU
Sep 24, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 13, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 12, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 12, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
May 21, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 21, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 20, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 8, 2025 REPR